Edward Jones's Insider Trades & SAST Disclosures

Edward Jones's most recent trade in Cytosorbents Corp was a trade of 22,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 2, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Cytosorbents Corp
Edward R. Jones Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Apr 2024 22,000 22,000 - - Stock Option (Right to Buy)
Cytosorbents Corp
Jones R. Edward Director Purchase of securities on an exchange or from another person at price $ 1.33 per share. 13 Dec 2023 7,519 88,834 (0%) 0% 1.3 10,000 Common Stock
Cytosorbents Corp
Jones Edward R. Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 13 Dec 2023 2,631 2,631 - - Common Stock Warrant (Right to Buy)
Cytosorbents Corp
Edward R. Jones Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jul 2023 20,000 20,000 - - Stock Option (right to buy)
Cytosorbents Corp
Edward R. Jones Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2022 18,975 18,975 - - Stock Option (right to buy)
Cytosorbents Corp
Edward R. Jones Director Purchase of securities on an exchange or from another person at price $ 2.24 per share. 16 May 2022 1,676 81,315 (0%) 0% 2.2 3,749 Common Stock
Cytosorbents Corp
Edward R. Jones Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Dec 2021 4,000 0 - - Stock Option (right to buy)
Cytosorbents Corp
Edward R. Jones Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. 09 Dec 2021 4,000 82,800 (0%) 0% 4.1 16,500 Common Stock
Cytosorbents Corp
Edward R. Jones Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.22 per share. 09 Dec 2021 3,161 79,639 (0%) 0% 5.2 16,500 Common Stock
Cytosorbents Corp
Edward R. Jones Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Apr 2021 17,250 17,250 - - Stock Option (right to buy)
Cytosorbents Corp
Edward R. Jones Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.35 per share. 18 Aug 2020 4,000 78,800 (0%) 0% 3.4 13,400 Common Stock
Cytosorbents Corp
Edward R. Jones Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Aug 2020 4,000 0 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades